Moreover, The Human Protein Atlas indicates that for stomach cancer (Figure 1C), low levels of Claspin expression are a prognostic marker for worse survival (https://www.proteinatlas.org/ENSG00000092853-CLSPN/pathology/stomach+cancer). This evidence concerns the gene CLSPN and gastric neoplasm.